Clival Database

Power BI Dashboard
Free Trial/Demo
Client Login

About Us
Clinical Trial Data
Glossary Terms Drug Development Process Therapy Area/ Disease Sponsor/ Organisation Orphan Drug Designation Fast Track Approval Breakthrough Approval
Licensing Opportunities
CRO
News Center
Pricing
Contact Us

Home
New Indication Trial

New Indication Trial

Recent News

Everest Medicin...

March 11,2022 12:40 PM

SciSparc Launch...

March 11,2022 12:38 PM

Health Canada A...

March 11,2022 12:37 PM

Cerveau Technol...

March 11,2022 12:34 PM

Lupin Launches ...

March 11,2022 12:33 PM

Huadong Becomes Strategic Partner In Asia For Heidelberg Pharma Strikes Deal Worth $0.9B
March 02,2022 10:00 AM

Innovent Announces The NMPA Granted New Indication Approval For BYVASDA® (Bevacizumab Biosimilar)
July 19,2021 02:54 PM

Categories

Approval
Licensing Deal
New Indication Trial
Discontinued/Warning
Clinical Trial Update
Acquisition/Merger
Odd/Bta
Patent

Clinical trials data Insight on over 3,00,000 clinical trials from Phase 0 to IV across all indication includes, Orphan disease and Therapy Area.

Terms & Conditions | Privacy Policy | Disclaimer | Sitemap

Quick Links

About Us
Contact us
Pricing
Licensing Opportunities
CRO
Refund Policy

C-89 1st Floor, Sector-65 Noida-U.P. 201301 (India)

INDIA : +91-120-6631301-335

US : +1-201-688-7280

sales@lifescienceintellipedia.com

info@lifescienceintellipedia.com

© Copyright 2021 All right reserved, Lifescience Intellipedia Pvt. Ltd.